Takeaway: GLP-1 Drugs Like Ozempic Cut Heart Attack Risk by 20% in Major Review

GMJ
By
Prof. Giorgi Pkhakadze
0 Min Read
Medical illustration showing heart protection from GLP-1 medications
Major international review finds GLP-1 drugs like Ozempic reduce heart attack risk by 20% and stroke risk by 18%. The cardiovascular benefits appear within 12-18 months regardless of diabetes status. — Photo: Haberdoedas Photography / Pexels
1 min read|33 words

✅ 3 key takeaways on GLP-1 heart benefits: 1) 20% reduction in heart attacks within 18 months 2) Benefits work beyond weight loss through anti-inflammatory effects 3) Clinical guidelines being updated for prevention strategies

Read the full article on GMJ Newsroom →

Was this article helpful?

Share This Article
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How one biotech startup transformed clinical trial failure into an AI-powered health technology breakthrough

A biotech startup has converted data from a failed clinical trial into…

The Hidden Cost of Secrecy: How Missing Research Data Undermines Clinical Guidance

Systematic reviews and meta-analyses that guide clinical practice are increasingly compromised by…

Corrected Global Data on Substance Use Burden Across 204 Countries Reveals Shifting Patterns

Nature Medicine has published a corrected Global Burden of Disease assessment of…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like